Eli Lilly Corp. buy melinda
Start price
11.12.14
/
50%
€60.32
Target price
11.06.15
€64.00
Performance (%)
23.71%
End price
11.06.15
€73.74
Summary
This prediction ended on 11.06.15 with a price of €73.74. The BUY prediction by melinda finished with a performance of 23.71%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Eli Lilly Corp. | -6.084% | -6.084% | 48.723% | 278.015% |
iShares Core DAX® | -3.429% | 3.133% | 15.455% | 14.827% |
iShares Nasdaq 100 | -6.121% | -1.433% | 16.794% | 27.167% |
iShares Nikkei 225® | -7.364% | 1.018% | 8.293% | -2.680% |
iShares S&P 500 | -4.366% | 0.247% | 18.541% | 32.687% |
According to melinda what are the pros and cons of Eli Lilly Corp. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Eli Lilly Corp. diskutieren
DIABETES
ENDOKRINOLOGIE
(Laufzeit überschritten)
Stopped prediction by melinda for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€403.60
14.05.23
14.05.23
€700.00
14.05.24
14.05.24
76.01%
15.05.24
15.05.24
Could be worthwhile Investment >10% per year
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€131.66
06.06.20
06.06.20
€205.00
04.11.21
04.11.21
77.81%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€73.17
11.05.18
11.05.18
€74.64
14.05.18
14.05.18
2.17%
14.05.18
14.05.18
Could be worthwhile Investment >10% per year
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€74.25
06.07.17
06.07.17
€77.57
19.12.17
19.12.17
6.09%
19.12.17
19.12.17
Could be worthwhile Investment >10% per year
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€82.32
06.07.17
06.07.17
€86.00
19.12.17
19.12.17
6.09%
19.12.17
19.12.17
Could be worthwhile Investment >10% per year
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€35.51
04.10.13
04.10.13
€40.00
04.04.14
04.04.14
23.65%
04.04.14
04.04.14
Could be worthwhile Investment >10% per year